Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ImmunoPharmaceutics Inc.

Division of Pfizer Inc.

Latest From ImmunoPharmaceutics Inc.

Structural Bioinformatics

Drug Discovery Tools; Bioinformatics. Structural Bioinformatics performs computational high-throughput screening with a 4-D approach to the generation of protein structures, that is, dynamic 3-D protein structures viewed through the fourth dimensionof time. It seeks to bridge the gap between novel gene-sequence data generated by genomic researchers and the 3-D structural information used by researchers in drug discovery.

BioPharmaceutical Research and Development Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • David McWilliams, Pres. & CEO
    Manfred E Wolf, PhD, VP, R&D
  • Contact Info
  • ImmunoPharmaceutics Inc.
    Phone: (619) 451-8400
    11011 Via Frontera
    San Diego, CA 92127